Filters

Human cytomegalovirus Uracil-DNA glycosylase (UL114)

Human cytomegalovirus Uracil-DNA glycosylase (UL114) size: 100ug 1741

Price 1741
Size 100ug
Long nameRecombinant Human cytomegalovirus Uracil-DNA glycosylase (UL114)
Alternative names Uracil-DNA glycosylase, involved in DNA repair, uracil-DNA glycosylase, uracil-DNA glycosylase
Gene nameUL114
Other gene names UDG, UL114, UL114
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, Uracil-DNA glycosylase (UL114) is a recombinant protein expressed in Baculovirus
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetcytomegalovirus Uracil-DNA glycosylase (UL114)
Short namecytomegalovirus Uracil-DNA glycosylase (UL114)
Species Humans, Human
Alternative name sapiens cytomegalovirus Uracil-Desoxyribonucleic acid glycosylase (UL114), H

Subscribe to our Newsletter